Pak kinases are a family of serine/threonine protein kinases homologous to Ste20p of yeast. Paks can be activated in vivo and in vitro by binding to GTP-bound Cdc42 and Rac1, members of the Rho family of small GTPases implicated in regulating the organization of the actin cytoskeleton. We have previously reported that the SH2/SH3-containing adaptor protein Nck binds Pak kinase through its second SH3 domain. Pak1 can be targeted to the membrane by Nck in response to tyrosine phosphorylation, and membrane association of Pak1 is sucient to increase its speci®c activity. The mechanism whereby Pak is activated by membrane localization, however, is unknown. We show here that expression of three proteins that inhibit Rho-family GTPases by dierent mechanisms (RhoGDI, Bcr and D57Y Cdc42) all block the activation of Pak by a membrane-targeted Nck SH3 domain, demonstrating that the in vivo activation of Pak1 induced by membrane localization is dependent on Rho-family GTPases. This implies that Pak activity can be regulated in cells both by the level of GTP loading of various Rho-family GTPases and the local concentration of Pak relative to these GTPases. Our data also suggest the existence of Rho-family GTPases in addition to Cdc42 and Rac1 that can activate Pak on membranes.
Introduction p21 activated protein kinase (Pak) comprises a family of serine/threonine kinases highly homologous to yeast Ste20p, which is involved in the mating response in Saccharomyces cerevisiae. Paks were originally identi®ed as protein kinases that bind the active (GTPbound) form of the Rho-family GTPases Cdc42 and Rac1 by ®lter overlay assay Manser et al., 1994; Martin et al., 1995) . Binding of Pak to GTP-bound Cdc42 or Rac1 results in an increase in its kinase activity, suggesting that Pak kinases function as eectors of Cdc42 and Rac. Cdc42 and Rac1 have been shown to be involved in regulating the organization of the actin cytoskeleton (Nobes and Hall, 1995; .
Genetic experiments in yeast have demonstrated that STE20 is required for mating in some strains, and is also required for some morphological changes, such as formation of mating projections upon pheromone stimulation and ®lamentous growth upon nitrogen starvation (Cherno, 1997; Herskowitz, 1995) . Ste20p activates a MAP kinase cascade which is essential for cell cycle control and the transcription of matingspeci®c genes in the mating response signal transduction pathway (Cherno, 1997; Herskowitz, 1995) . Genetic epistasis studies have positioned STE20 upstream of STE11, which encodes a MAP kinase kinase kinase (analogous to vertebrate Raf) (Leberer et al., 1992) . The yeast CDC42 gene product is required for cell polarity (Johnson and Pringle, 1990 ) and its product has been shown to bind Ste20p (Manser et al., 1994) . Regulation of Ste20p by Cdc42p is therefore likely to link the morphogenesis and pheromone response pathways (Herskowitz, 1995) .
In mammalian cells there are at least three isoforms of Pak, Pak1 (Paka) (Brown et al., 1996; Knaus et al., 1995; Manser et al., 1994; Martin et al., 1995) , Pak2 (Pakg) Teo et al., 1995) and Pak3 (Pakb) (Bagrodia et al., 1995b; Manser et al., 1995) . These Pak family protein kinases share similar structural features in that they all have an SH3-binding proline-rich motif and a p21-Binding Domain (PBD) at their amino termini and a catalytic domain at their carboxyl termini. The proline-rich motif and the PBD mediate binding to SH3 domains and Rho-family GTPases, respectively (Cherno, 1997) .
In lymphocytes infected in vitro by HIV or SIV, a Pak-like kinase has been shown to associate with and be activated by the HIV regulatory protein Nef (Lu et al., 1996; Nunn and Marsh, 1996; . There is also evidence that the association and activation of this Pak-like kinase is dependent on Cdc42 and Rac1, and activation of the Pak-like kinase leads to the activation of the serum response pathway (Lu et al., 1996) . Moreover, the Nef-mediated activation of a Pak-related kinase correlates with the induction of high virus loads and the development of AIDS in the infected host . These ®ndings suggest that the Pak-like kinase might be involved in the activation of lymphocytes, which is critical for high viremia and progression of AIDS (Cullen, 1996) , and establish this kinase as a potential target for treatment of HIV infection.
The Pak kinases represent one of the major known eectors of Cdc42 and Rac1. The Rho-family GTPases have all been shown to be involved in the regulation of actin reorganization; speci®cally, Cdc42 induces the formation of ®lopodia or microspikes, while Rac1 induces membrane ruing or formation of lamellipodia (Nobes and Hall, 1995; . There is evidence that Pak1 is also involved in actin reorganization in some mammalian cells (Manser et al., 1997; Sells et al., 1997) , and in Drosophila Pak is enriched in the leading edge of embryonic epithelial cells undergoing dorsal closure (Harden et al., 1996) .
However, it has also been reported that the morphology changes induced by Cdc42 and Rac1 do not depend on their ability to bind Pak (Lamarche et al., 1996; Westwick et al., 1997) .
Mammalian Pak kinases have been reported to activate the JNK, p38 and Erk MAP kinase pathways under dierent conditions (Bagrodia et al., 1995a; Brown et al., 1996; Frost et al., 1996 Frost et al., , 1997 Lu et al., 1997; Polverino et al., 1995; Zhang et al., 1995) . Mammalian Cdc42 and Rac1 stimulate the stressactivated signal transduction pathways leading to activation of JNK and p38 (Coso et al., 1995; Minden et al., 1995) . It is widely believed that Pak kinase is the mediator between Cdc42 and Rac1 and the JNK signal transduction pathway. However, mutagenesis studies of the`eector loop' of Rac1 suggest that the activation of JNK by Rac1 does not depend on Pak1 binding, although there is some correlation between Pak and JNK activation (Joneson et al., 1996; Lamarche et al., 1996; Westwick et al., 1997) . A kinase-de®cient Pak1 mutant has been shown to inhibit Ras-induced transformation in rat ®broblasts and this inhibition could not be uncoupled from Erk signaling, suggesting a role for Pak in Erk activation (Tang et al., 1997) . There is also evidence that Pak kinases are involved in the regulation of apoptosis (Faure et al., 1997; Rudel and Bokoch, 1997) .
Previously, we and several other groups have reported that Pak1 associates with the second SH3 domain of the SH2/SH3 containing adaptor protein Nck Galisteo et al., 1996; Lu et al., 1997) . SH2/SH3 adaptor proteins consist entirely of modular protein binding domains, and mediate the formation of protein complexes involved in signaling (Cohen and Baltimore, 1995; Pawson, 1995) . There is evidence that Nck recruits Pak1 to the membrane in response to tyrosine phosphorylation, for example of growth factor receptors, and that membrane localization itself is sucient for the activation of Pak1 (Lu et al., 1997) . However, the mechanism of Pak activation at the membrane is not understood. There are several possible mechanisms for Pak activation: (1) membrane localization increases its accessibility to the GTPbound forms of Cdc42 and Rac1 (and perhaps other small GTPases); (2) Pak1 is phosphorylated and activated by some unidenti®ed kinase(s) at the membrane; (3) Pak1 is activated by autophosphorylation in trans due to high local concentration at the membrane.
Although activated Cdc42 and Rac1 can dramatically stimulate the kinase activity of Pak1 in vivo and in vitro, there is no evidence that the activation of Pak1 in vivo at the membrane in response to tyrosine phosphorylation is dependent on GTP-bound Cdc42 or Rac1. While it was reported that some growth factors including EGF and PDGF can activate Pak1 (Galisteo et al., 1996) , in our hands Pak activation by these growth factors is modest and variable in 293T cells, making it very dicult to study the mechanism of Pak1 activation. In contrast the activation of Pak1 by membrane localization via myristoylated Nck SH3 domain is robust, providing an excellent model system to study relocalization-mediated activation of Pak.
In this study we utilize down-regulators of Rhofamily GTPases to address whether the activation of Pak kinase is dependent on any of these Rho-family GTPases. We ®nd that the activation of Pak1 in vivo induced by membrane-associated Nck SH3 domain can be blocked by expression of RhoGDI, the GAP domain-containing protein Bcr, and a dominant negative allele of Cdc42, suggesting the activation of Pak1 at the membrane is dependent on Rho-family proteins. However the activation in vivo at the membrane cannot be blocked by 3BP-1, which we show inhibits both endogenous Cdc42 and Rac1, suggesting that other Rho-family GTPases in addition to Cdc42 and Rac1 can activate Pak1 at the cell membrane. Our data argue against a GTPaseindependent mechanism for Pak activation, and suggest that the in vivo activity of Pak is determined by a combination of the levels of GTP-loaded Rhofamily GTPases and local concentrations of Pak and these GTPases.
Results
Activation of Pak1 by both membrane recruitment and constitutively active forms of Cdc42 and Rac1
Pak kinases were originally identi®ed as kinases which can be activated by GTP-bound Cdc42 and Rac1 Manser et al., 1994) , and they have been proposed to be direct downstream eectors of Cdc42 and Rac1. We cotransfected GST-tagged constitutively active V12 mutants (V14 in case of Rho) of Rho-family GTPases and Ras together with Myc-tagged Pak1 into human 293T cells, and assayed Pak1 speci®c activity in vitro. Consistent with the results of others, in this system we found that Pak1 could be activated in vivo by expression of the active forms of Cdc42 and Rac1 but not RhoA or Ras (Figure 1 , second panel from top, lanes 6 ± 9). Immunoblot analysis of the Pak1 immunoprecipitates showed that the V12 Cdc42 and Rac1 mutants were tightly associated with Pak1 ( Figure 1 , third panel from top, lanes 6 and 7), as expected if Pak1 kinase were activated by binding to the GTP-bound form of Cdc42 and Rac1.
We have previously reported that Pak1 is activated when it is recruited to the membrane by the second SH3 domain of Nck (Lu et al., 1997) . It has been reported that Nck can regulate p21ras-dependent gene transcription through interaction with SOS, an activator of Ras nucleotide exchange (Hu et al., 1995) . This raised the possibility that activation of Pak1 via myristoylated Nck SH3(2) is an indirect eect of activation of the Ras/Raf pathway due to membrane relocalization of SOS. We found, however, that the activation of Pak1 induced by myristoylated Nck SH3(2) could not be blocked by coexpression of the N17 dominant negative Ras mutant (Figure 1, lane 5) . This result, in combination with the failure of the activated V12 Ras mutant to activate Pak (Figure 1 , lane 9) strongly suggests that the activation of Pak1 by Nck SH3 domain is not due to the Nck-SOS association.
The activation of Pak1 at the membrane is dependent on Cdc42, Rac1, or a related protein
In order to understand the mechanism of activation of Pak on the membrane, we wished to test if the activation of Pak1 was Cdc42-or Rac1-dependent. A straightforward approach would be to test whether Pak1 mutants lacking the p21-Binding Domain (PBD) motif could be activated in cells overexpressing the myristoylated Nck SH3 domain. However, PBD mutants such as L83, L86 Pak1 are constitutively active (Tang et al., 1997 and data not shown), making them unsuitable for analysis of the mechanism of Pak activation. Instead, we chose to test the ability of known down-regulators of Cdc42 or Rac1 signaling to block Pak1 activation.
Like other members of the G protein superfamily, the Rho-family GTPases function as molecular switches, cycling between an inactive GDP-bound conformation and an active GTP-bound conformation (Hall, 1994) . The active form can be induced by Guanine nucleotide Exchange Factors (GEFs), which catalyze the release of GDP, leading to rapid binding of GTP due to its higher intracellular concentration. Intrinsic GTPase activity ultimately results in the cleavage of GTP and inactivation, and this GTPase activity can be greatly accelerated by GTPase Activating Proteins (GAPs). The GDP-bound GTPases bind RhoGDI, which is a nonspeci®c Guanine nucleotide Dissociation Inhibitor for all Rho-family GTPases (Hart et al., 1992) . RhoGDI down-regulates Rho-family GTPases by blocking the release of GDP and by sequestering the GTPase in the cytosol. How RhoGDI and GEFs coordinate is currently unclear (Hall, 1994; Ridley, 1996) . By using negative regulators of Rho GTPases including Rho-GDI, GAP proteins, and dominant negative mutants of Cdc42 or Rac1 which are known to sequester GEFs for the endogenous Cdc42 or Rac1, we can address whether Pak1 activation at the membrane is dependent on Cdc42 or Rac1.
RhoGDI was ®rst utilized since it is a nonspeci®c inhibitor for all the Rho-family GTPases. Myc-tagged Pak1 was cotransfected with myristoylated Nck SH3 domain and increasing amount of RhoGDI. Pak1 was immunoprecipitated with anti-Myc antibody and subjected to immunoblotting and in vitro kinase assay. The activation of Pak1 induced by myristoylated Nck SH3 was strongly inhibited by RhoGDI ( Figure 2 , middle panel). The inhibition of Pak1 activation by RhoGDI suggests that Pak1 activation at the membrane induced by myristoylated Nck SH3 domain is dependent on the GTP-bound form of a Rho-family GTPase.
To further dissect which speci®c proteins are involved in Pak activation, we utilized GAP proteins which have dierent speci®city towards Cdc42, Rac1 and Rho. We utilized three GAP proteins in this study: Bcr, RhoGAP, and 3BP-1. Bcr contains a domain with strong GAP activity towards Cdc42 and Rac1, but not RhoA (Diekmann et al., 1991; Ridley et al., 1993) . 3BP-1, a GAP protein that binds the SH3 domain of Abl, has the same speci®city as Bcr except that the GAP activity is relatively less potent (Cicchetti et al., 1995) . RhoGAP has GAP activity toward Cdc42 and Rho, but not Rac1 (Lancaster et al., 1994; Ridley et al., 1993) . Figure 3 shows that overexpression of Bcr GAP could block the activation of Pak1 induced by myristoylated Nck SH3, while RhoGAP and 3BP-1 had no eect. Western blotting of the whole cell lysates con®rmed the expression of Bcr, RhoGAP and 3BP-1. Failure to block Pak1 activation by RhoGAP and 3BP-1 might be due to low in vivo GAP activity or to the dierent speci®city of these GAP proteins or both. However the fact that Bcr could block the activation of Pak1 strongly suggests that the activation of Pak1 is dependent on Figure 1 Pak1 is activated by membrane localization and by activated Cdc42 and Rac1, and the activation of Pak1 by membrane localization is not dependent on Ras. One mg of plasmid expressing Myc epitope-tagged Pak1 was cotransfected into 293T cells with the constructs as labeled.`Src SH3(2)' expresses the second SH3 domain of Nck fused to the N-terminal myristoylation signal of Src. All the Rho-family GTPase mutants and the Ras mutant were GST-tagged and all the Nck SH3 mutants were HA epitope-tagged. Pak1 was immunoprecipitated with anti-Myc monoclonal antibody and immunoprecipitates were subjected to Western blot analysis with anti-Myc antibody to con®rm the protein levels (top panel), and to in vitro kinase assay using histone H4 as substrate (second panel from top). Anti-Myc immunoprecipitates were also subjected to Western blot analysis with anti-GST antibody to visualize Pak1-associated Rho-family GTPases (third panel from top). Anti-GST Western blot of the whole cell lysate con®rmed the expression of the GST-tagged Rho-family GTPases (bottom panel). Anti-HA Western blot analysis of whole cell lysates con®rmed that the expression levels of the Nck SH3 domain in dierent samples were similar (data not shown). This experiment and all the following experiments were repeated at least twice and results were highly reproducible Rac1, Cdc42, or a similar protein that is a substrate for the GAP activity of Bcr.
Eects of dominant negative Rac1 and Cdc42 on Pak activation
To further investigate the requirements for Pak1 activation, we utilized dominant negative Rac1 and Cdc42 mutants which function by sequestering the endogenous GEFs, thereby preventing the endogenous wild-type Cdc42 and Rac1 from being activated. The most commonly used dominant negative GTPases (for both the Ras and Rho families of small GTPases) have an asparagine mutation at residue 17 which disrupts magnesium binding (Milburn et al., 1990; Pai et al., 1989 Pai et al., , 1990 , resulting in a much lower anity for guanine nucleotide. GST-tagged N17 Rac1 was cotransfected with Myc-tagged Pak1 with or without myristoylated Nck SH3 domain. The activation of Pak1 was not blocked by N17 Rac1 over a wide range of mutant Rac1 expression (Figure 4a ). This experiment suggests that Pak1 activation induced by membrane association is not dependent on GTPloaded Rac1.
We performed similar experiments with the N17 Cdc42 mutant, and to our surprise found that in the presence of myristoylated Nck SH3 it reproducibly induced a concentration-dependent stimulation of Pak1 activity above the level seen with myristoylated SH3 alone (Figure 4b ). In the absence of the myristoylated Nck SH3 domain N17 Cdc42 had no eect, suggesting that the eect was dependent on membrane localization (Figure 4c ). The N17 Cdc42 used in this study has an N-terminal GST tag, but an independently derived N17 Cdc42 mutant with an HA epitope tag gave the same result (data not shown). To con®rm that the (Figure 4d ). These experiments demonstrate that membrane localization (and not Nck SH3 binding) is required for activation by N17 Cdc42. Although the above results suggested that neither Cdc42 nor Rac1 activity was necessary for activation of Pak1 on the membrane, we considered the possibility that the activity of either alone was sucient. In order to simultaneously block GEFs speci®c for both Cdc42 and Rac1, we cotransfected both N17 Cdc42 and N17 Rac1 (Figure 4e ). In this case Pak1 was further activated to the same extent as with N17 Cdc42 alone, again suggesting that Pak1 activation does not speci®cally require GTP-bound Cdc42 or Rac1. This experiment also demonstrates that the N17 Cdc42 and Rac1 mutants were expressed at similar levels.
Because our observation that dominant negative Cdc42 stimulated the activation of Pak1 on membranes was very unexpected, we wished to test the activity of another dominant negative allele of Cdc42. A second dominant negative mutant for small GTPases, D57Y, has been described (Stowers et al., 1995) . This mutant was originally isolated as a strong dominant inhibitory allele of Ras in yeast (Jung et al., 1994) . To our surprise, we found that the activation of Pak1 could be strongly inhibited by the D57Y mutant of Cdc42 over a wide range of expression levels ( Figure 5 ). Similarly, we have found that expression of the D57Y mutant of Cdc42 decreased the activity of myristoylated Pak1 to the level of unmyristoylated Pak1 (data not shown). These results strongly suggest that the activity of some small GTPase, whose endogenous GEFs can be blocked by D57Y Cdc42 (but not by N17 Cdc42), is required for the activation of Pak1 on membranes.
In vivo eects of dominant negative mutants, RhoGDI and GAPs on GTP-Cdc42 and GTP-Rac1 levels
One of the concerns with these experiments is whether the dominant negative mutants and GAPs actually function as expected as down-regulators of endogenous Cdc42 and Rac1. A novel technique to determine the levels GTP-bound endogenous Ras has been developed, which uses the Ras Binding domain (GST-RBD) of Raf to isolate GTP-Ras (Taylor and Shalloway, 1996) . We used a similar scheme to detect the active forms of endogenous Cdc42 and Rac1. Because the PBD domain in the N-terminus of Pak1 binds only the active, GTPbound form of Cdc42 and Rac1 Manser et al., 1994; Martin et al., 1995) , it can be used as a probe to quantitate endogenous GTP-bound Rac1 and Cdc42 in transfected cells. A similar strategy has recently been employed by Lim and colleagues to analyse the GTP loading of overexpressed Cdc42 and Rac1 (Manser et al., 1998) . However, instead of using beads coupled to puri®ed Pak N-terminus to isolate GTP-bound Rho GTPases from lysates in a`pull-down' assay, we chose to cotransfect plasmid encoding the Pak N-terminus fusion protein (GST-Pak1N) into the cells along with various inhibitors because this more closely approximates the experimental conditions for activation of transfected Pak1 in vivo by myristoylated Nck SH3 domain (e.g. Figures 1 ± 5) . A further advantage of this approach is that the success of the experiment does not depend on transfection eciency, because only successfully tranfected cells are scored for GTPase binding. In our experience this approach is more sensitive than the pull-down assay using puri®ed Pak N-terminus (data not shown).
Plasmid expressing the N-terminus of Pak1 as a GST fusion was cotransfected into 293T cells along with dominant negative Cdc42 or Rac1, RhoGDI, or GAPs. Forty-eight hours after transfection, the Pak1 N-terminus was rapidly collected and bound Cdc42 and Rac1 were detected by immunoblotting with Cdc42-or Rac1-speci®c antibody. As shown in Figure  6 , there were detectable levels of GTP-bound Cdc42 and Rac1 in unstimulated 293T cells ( Figure 6, lane 2) . This is consistent with our observation that Pak1 can be activated in unstimulated cells when it is relocalized to the membrane, where GTP-bound Cdc42 and Rac1 are found. The N17 Cdc42 mutant had a relatively minor eect on both Cdc42 and Rac1, while N17 Rac1 decreased GTP-Rac1 only slightly and had no eect on Cdc42. In contrast, D57Y Cdc42 had a very strong inhibitory eect on endogenous Cdc42 but almost no eect on Rac1. RhoGDI, Bcr and 3BP-1 all strongly blocked endogenous Cdc42 and Rac1 activity, while RhoGAP had little eect.
The fact that Pak1 activation induced by myristoylated Nck SH3 domain could not be blocked by 3BP-1 (Figure 3c ), which we show here inhibits both endogenous Cdc42 and Rac1, suggests that neither GTP-Cdc42 nor GTP-Rac1 is required for Pak activation at the membrane. Furthermore, GTP-Rac1 alone cannot be sucient for Pak1 activation at the membrane since GTP-Rac1 levels were not aected by D57Y Cdc42 (Figure 6 , lane 5), which strongly inhibited Pak1 activation ( Figure 5 ). These data are summarized in Table 1 . Taken together, our results suggest that there are redundant Rho-family GTPases at the membrane that can activate Pak1.
Discussion
The p21 Activated Kinases (Paks) are a family of serine/threonine kinases de®ned by their ability to be activated directly by binding to GTP- Harden et al., 1996; Manser et al., 1997; Sells et al., 1997) . Pak1 has a substrate speci®city similar to that of myosin I heavy chain kinase (MIHCK) when assayed with synthetic peptide substrates, and Pak1 phosphorylates the heavy chain and activates Acanthamoeba myosin I as does MIHCK (Brzeska et al., 1997) . Although it has been reported that Rac1 mutants that cannot bind to Pak1 can still induce formation of lamellipodia (Lamarche et al., 1996; Westwick et al., 1997) , and there is evidence for other eectors of Rhofamily GTPases that can induce morphological changes (Symons et al., 1996) , it is likely that Pak plays an important role in the biological eects of Rac and Cdc42. The SH2/SH3 containing adaptor Nck has been proposed to link growth factor receptors to the activation of Pak1 Galisteo et al., 1996; Lu et al., 1997) . We have reported previously that Nck can target Pak to the membrane through its second SH3 and that membrane association is sucient for Pak1 activation (Lu et al., 1997) . In this paper we present evidence that Pak1 activation at the membrane is dependent on a Cdc42-like activity, as the Pak1 activation induced by myristoylated Nck SH3 can be blocked by overexpression of RhoGDI, Bcr, and by the D57Y dominant negative mutant of Cdc42. The fact that Pak1 activation by membrane localization cannot be blocked by 3BP-1, which we show inhibits the in vivo activity of Cdc42 and Rac1, suggests there might be other Rho-family GTPase(s) at the membrane that can also activate Pak1. Since membrane localization alone is sucient to activate Pak1 in 293T cells (Lu et al., 1997) , these results imply that there are signi®cant levels of GTP-bound Rho-family GTPases at the membrane even in unstimulated 293T cells; this is con®rmed directly by the experiment shown in Figure  6 .
GTP-bound Cdc42 and Rac1 can directly activate Pak1 by binding to its N-terminal PBD motif, and GTP-bound endogenous Cdc42 and Rac1 are most likely localized at the membrane (Hall, 1994 ). An interesting distinction thus emerges between activation of Pak by Rho-family GTPases and activation of the Raf kinase by the small GTPase Ras. GTP-bound Ras, which is exclusively localized on membranes, is known to recruit Raf to the membrane where it is activated. Although there is still disagreement about the speci®c mechanism, activation of Raf is clearly not a direct eect of Ras binding but instead is due to interaction with other proteins (such as kinases) on the membrane (Morrison and Cutler, 1997) . Therefore GTP loading of Ras triggers Raf activation by relocalizing it to the vicinity of its activators. In the case of Pak, the role of the GTPase is reversed: it has the ability to directly activate Pak, but apparently its anity for the kinase is suciently low that normally only a small fraction of the Pak in the cell is bound to activated GTPases. Membrane localization of Pak would be predicted to greatly increase its local concentration with respect to GTP-loaded Rho-family GTPases, favoring binding and thus Pak activation. Rho-family GTPases may have a modest eect on stabilizing the membrane localization of Pak1, however, as suggested by the decreased association of Pak with membranes in cells expressing RhoGDI or Bcr (Lu and Mayer, unpublished observation) .
Presumably under dierent physiological conditions either the localization of Pak or the GTP loading of Rho-family GTPases (or both) could be limiting for Pak activation. In our system in 293T cells, localization appears to be limiting, though increasing the amount Figure 6 The eect of RhoGDI, GAPs, and dominant negative mutants of Cdc42 and Rac1 on endogenous Cdc42 and Rac1. EBG vector or EBG Pak1N (expressing GST fused to the Nterminus of Pak1) was cotransfected with dominant negative mutants, RhoGDI or GAPs as indicated. Forty-eight hours after transfection, cells were lysed and GST or GST-Pak1N was collected with glutathione agarose beads. Amounts of Cdc42 and Rac1 bound to GST-Pak1N were determined by immunoblotting (top two panels). Amounts of Cdc42, Rac1, GST, GST-Pak1N in whole cell lysates were also determined by immunoblotting using anti-Cdc42, anti-Rac1, and anti-GST antibodies (bottom three panels). D57Y Cdc42 migrates more quickly and HA-tagged N17 Cdc42 and Rac1 migrate more slowly than the endogenous gene products, and do not appear on the portion of the blot shown in the ®gure of GTP-loaded Cdc42 or Rac1 in the cell (by expressing V12 Cdc42 or Rac1) can saturate Pak activation and abrogate the requirement for membrane localization (Figure 1) . Conversely, it is likely under other conditions, where very low amounts of GTPloaded Rho-family members are present on the membrane, that membrane localization would be insucient to activate. Such a mechanism, in which two inputs are required for full activation, seems well suited to regulating systems such as the actin cytoskeleton where spatial organization is required. One could easily envision how a combination of relocalization of Pak (mediated at least in part by Nck, which can bind to tyrosine phosphorylated proteins via its SH2 domain) and localization of activated, GTP-bound Rho-family GTPases could generate sharp spatial gradients in Pak activity. In this light it is interesting that Nck is present in the growth cones of Drosophila neurons, where Nck mutation has been shown to lead to defects in axon path®nding and targeting (Garrity et al., 1996) . Nck can bind via its SH2 domain to the Eph receptor, which is known to play a role in axon guidance (Holland et al., 1997; Stein et al., 1998) . Rac has also been shown to be involved in axon outgrowth in Drosophila and in mice (Luo et al., 1994 (Luo et al., , 1996 . It seems likely that Nck plays a role in integrating information from spatial gradients of tyrosine phosphorylated receptors and GTP-bound Rho-family GTPases at the growth cone. We show here that three agents that block the activity of Rho-family GTPases via completely dierent mechanisms (D57Y Cdc42, Bcr and Rho-GDI) all prevent activation of Pak at membranes. What is the identity of the GTPase that activates Pak on membranes? Both Cdc42 and Rac1 have been shown to activate Pak1 in vivo and in vitro. However our data suggest that there might be other Rho-family GTPases that can activate Pak1, as we show that 3BP-1 strongly decreased in vivo levels of GTP-bound Cdc42 and Rac1 but did not inhibit Pak1 activation by membrane localization (Figure 6) . A further implication of our studies is that endogenous Rac1 alone is insucient to activate Pak1 on membranes, as we show that D57Y Cdc42 blocked Pak1 activation strongly while having almost no eect on endogenous levels of GTP-Rac1. This may be because the levels of GTPbound Rac1 in unstimulated cells are insucient to stimulate Pak, or endogenous GTP-Rac1 may be localized in a dierent subcellular membrane compartment than Pak1.
Based on studies with Ras, it has been long assumed that N17 Cdc42 and Rac1 function as dominant negative mutants. In this work we have directly measured the levels of GTP-bound Cdc42 and Rac1 in 293T cells overexpressing the N17 mutants. We show that neither N17 Rac1 nor N17 Cdc42 has a strong inhibitory eect on the endogenous Cdc42 and Rac1 in these cells under our experimental conditions even at high levels of expression. This unexpected result suggests that negative results in experiments using these N17 mutants must be interpreted with caution until their eects on the activity state of their endogenous counterparts can be assessed directly. For example, it has recently been shown that although Raf activation by PKC could not be blocked by N17 Ras, experiments involving Raf mutants unable to bind Ras or injection of neutralizing Ras antibodies suggested that Ras activity is in fact required for Raf activation by PKC in vivo (Marais et al., 1998) . It seems likely that the ability of N17 Cdc42 and Rac1 to act as dominant negatives will be dependent on factors such as expression level and the presence of other proteins in the cell.
One fascinating aspect of our studies is the observation that the activation of Pak1 by myristoylated Nck SH3 domain was inhibited by one dominant negative mutant of Cdc42 (D57Y) but further activated by a second, less potent dominant negative mutant (N17). The stimulatory eect of the N17 mutant over a wide range of protein expression levels suggests that its behavior is fundamentally dierent from that of the D57Y mutant (which consistently inhibited over a similar range of expression). Studies in yeast with N17 Ras and D57Y Ras showed that the D57Y mutant has a much stronger phenotypic eect than the N17 mutant. D57Y Ras inhibited conjugation, sporulation, and morphology change, while N17 Ras only blocked conjugation of ®ssion yeast (Jung et al., 1994) . Biochemical studies demonstrated that both mutants have a defect in the guanine nucleotide-dependent release from the exchanger Cdc25, with D57Y having the more severe defect (Jung et al., 1994) . The simplest explanation for our results is that 293T cells contain a GEF that is strongly inhibited by D57Y but not by N17 Cdc42.
The surprising ability of N17 Cdc42 to superactivate membrane-localized Pak1 is currently unexplained. An interesting possibility, which would also account for the inability of 3BP-1 to inhibit Pak activation, is the existence of another Rho-family GTPase (in addition to Cdc42 and Rac1) that can activate Pak. GTP loading of such a GTPase would be inhibited by RhoGDI, BCR, and D57Y Cdc42, and stimulated by N17 Cdc42. One could imagine a scenario in which weak inhibition of nucleotide exchange on endogenous Cdc42 by the N17 mutant might lead, through a feedback mechanism, to superstimulation of a GEF for the novel Rho-family GTPase. Others have noted a complex interplay in neuronal cells between the activation or inhibition of Cdc42 and Rac1 on the one hand and RhoA on the other, consistent with the idea that inhibition of one Rho-family GTPase can lead to the activation of other family members (Kozma et al., 1997) .
The existence of Rho-family GTPases other than Cdc42 and Rac1 with the ability to activate Pak, while speculative, is not far-fetched. There are a number of Rho-related proteins that are as yet incompletely characterized (Hall, 1994; Ridley, 1995 Ridley, , 1996 . An intriguing candidate is the recently described mig-2 protein, which was isolated in C. elegans as a mutant aecting axon migration (Zipkin et al., 1997) . The axon phenotype of mig-2 is suggestive in light of the axon migration and path®nding phenotype of Nck mutants in Drosophila (Garrity et al., 1996) . Activated mig-2 mutations aect many more cells than do mig-2 null mutations, and double mutants carrying mig-2 null mutations along with weak mutations in unc-73, a putative exchange factor for small GTPases, showed new phenotypes besides defects in cell migration. These results suggest that the mig-2 protein functions redundantly with other Rho-family GTPases. In this study, we provide evidence that multiple Rho-family GTPases are capable of activating Pak1 in mammalian cells. Further experiments will be required to identify the speci®c Rho-family GTPases and GEFs involved in Pak activation on membranes in dierent cell types.
Materials and methods

Plasmids
N-terminal Myc epitope-tagged and C-terminal in¯uenza virus hemagglutinin (HA) epitope-tagged human Pak1, HA-tagged myristoylated and unmyristoylated human Nck SH3(2), and myristoylated SH3(2)K143 mutant were previously described (Lu et al., 1997) . GST-tagged human V12 Cdc42, V12 Rac1, V14 RhoA, N17 Cdc42, and N17 Rac1 in the EBG vector, and HA-tagged N17 Cdc42 and Rac1 in pcDNA3 were generously provided by M Chou (Chou and Blenis, 1996) . Human D57Y Cdc42 in pcDNA3 was provided by J Settleman (Stowers et al., 1995) . Fulllength human Bcr in pCMV5 was provided by R KhosraviFar. The full length 3BP-1 was cloned into the pEBB vector by polymerase chain reaction from a murine cDNA library. A clone encoding amino acids 231 ± 440 of human p50 RhoGAP was kindly provided by R Cerione and subcloned into the pEBB-HA vector to encode RhoGAP protein with a C-terminal HA tag. RhoGDI in pcDNA3 was kindly provided by A Rana. Dominant negative Cdc42 and Rac1 mutants were sequenced to con®rm the presence of expected mutations.
Mammalian cell transfection, immunoprecipitation and in vitro kinase assay 293T cells were transfected by the calcium phosphate method as described (Lu et al., 1997) . The cells were lysed 48 h after transfection in 1 ml Kinase Lysis Buer (KLB) (25 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 10 mM sodium pyrophosphate, 10 mM bglycerophosphate, 1 mM sodium orthovanadate, 10% glycerol, 1 mM PMSF and 20 mg/ml aprotinin) per 10-cm dish. The amount of cell lysate used for immunoprecipitations was normalized by test immunoprecipitation and immunoblot analysis. One mg of monoclonal or anitypuri®ed polyclonal antibody was incubated with cell lysate for 2 h at 48C and precipitated with protein G Sepharose (Pierce). Immunoprecipitates were washed extensively with KLB before immunoblotting or in vitro kinase assays.
Immunoblotting was performed utilizing the Pierce Super Signal chemiluminescent substrate system. In vitro kinase assays of immunoprecipitates were performed in 50 mM HEPES pH 7.5, 10 mM MgCl 2 , 100 mM ATP and 10 mCi [g-32 P]ATP for 10 min at 308C with 0.2 mg/ml Histone H4 as substrate.
Polyclonal antibodies for immunoblotting recognizing human Bcr, RhoGDI, Cdc42, and the Myc epitope tag monoclonal antibody 9E10, were from Santa Cruz Biochemicals. Anti-Rac1 monoclonal antibody was from Upstate Biotechnology Inc. The antibody recognizing the HA epitope tag was from Berkeley Antibody Co. The anti-GST antibody was anity-puri®ed rabbit polyclonal antibody.
Activation and inhibition of Pak1 by regulators of Rho-family GTPases and myristoylated Nck SH3 domain
One mg plasmid encoding Myc-tagged human Pak1 was cotransfected with 4 mg of plasmid DNA coding for myristoylated Nck SH3 domain and/or 2 mg plasmid DNA encoding constitutively active forms of Rho-family GTPases. For the inhibition of Pak1 activity by RhoGDI, Bcr GAP, dominant negative Cdc42 or Rac1, increasing amounts (from 0.5 ± 16 mg) of plasmid DNA for these proteins were cotransfected with 1 mg of plasmid DNA coding for Myc-tagged Pak1 and 4 mg plasmid DNA for myristoylated Nck SH3 domain. For N17 Ras, 4 mg of plasmid was transfected. For the combination of N17 Rac1 and N17 Cdc42, 4 mg of each were used. Forty-eight hours post-transfection, cells were lysed in 1 ml ice-cold KLB. The Myc-tagged Pak1 was immunoprecipitated with 1 mg monoclonal anti-Myc antibody 9E10, immunoprecipitates were washed three times with KLB and once with kinase buer (50 mM HEPES pH 7.5, 10 mM MgCl 2 ) and subjected to in vitro kinase assay as above. Western blotting of whole cell lysates was performed to con®rm the expression of Rho-family GTPases and their regulators.
Eects of RhoGDI, GAP proteins, and dominant negative mutants of Cdc42 and Rac1 on endogenous Cdc42 and Rac1
Four mg plasmid encoding the N-terminal 288 amino acids of Pak1 as a GST fusion protein (EBG Pak1N) or control vector EBG were transfected with 16 mg of plasmid encoding dominant negative mutants, GAPs, or RhoGDI. In this experiment the N17 Cdc42 and Rac1 constructs were tagged with the HA epitope. Cells were collected and lysed in 1 ml Rac Lysis Buer (20 mM Tris pH 7.5, 2 mM MgCl 2 , 0.5% Nonidet NP40, 150 mM NaCl, 1 mM DTT) per dish 48 h posttransfection, and 200 ml of cell lysate was immediately incubated with 20 ml glutathione agarose beads for 30 min with rotation. The beads were then collected, washed, split into two parts and subjected to immunoblot analysis to detect bound Cdc42 and Rac1 using anti-CDC42 and anti-Rac1 antibody.
